SAN DIEGO, Nov. 15 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated announced today that the Company will webcast its annual meeting with institutional investors and financial analysts in New York on Thursday, November 29, 2007, at approximately noon Eastern Time. The event will feature presentations on Gen-Probe’s current business and future growth strategies by several Company executives. The meeting and webcast will conclude at approximately 3:30 p.m. Eastern Time.
In addition, the Company will present at the Lazard Capital Markets Fourth Annual Health Care Conference in New York on Tuesday, November 27, 2007 at approximately 4:30 p.m. Eastern Time, and at the 19th Annual Piper Jaffray Health Care Conference in New York on Wednesday, November 28, 2007 at approximately 10:30 a.m. Eastern Time.
Live webcasts of each event may be accessed on the investment information section of the Company’s web site at http://www.gen-probe.com. Replays of the webcasts will be available on the same web site for 30 days following the events.
About Gen-Probe
Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 24 years of NAT expertise, and received the 2004 National Medal of Technology, America’s highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including the Form 10-Q for the period ended September 30, 2007, and all subsequent periodic filings made with the SEC. We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.
Paula Izidoro
Investor Relations
858-410-8904
CONTACT: Paula Izidoro, Investor Relations of Gen-Probe Incorporated,
+1-858-410-8904
Web site: http://www.gen-probe.com/
